BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 22171583)

  • 1. Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.
    Gensicke H; Leppert D; Yaldizli Ö; Lindberg RL; Mehling M; Kappos L; Kuhle J
    CNS Drugs; 2012 Jan; 26(1):11-37. PubMed ID: 22171583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific immune intervention with monoclonal antibodies for the treatment of multiple sclerosis.
    Trebst C; Voss E; Skripuletz T; Stangel M
    Curr Med Chem; 2010; 17(7):640-50. PubMed ID: 20088763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis - established and novel therapeutic approaches.
    Ehling R; Berger T; Reindl M
    Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):3-15. PubMed ID: 20236038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies in the treatment of multiple sclerosis.
    Di Pauli F; Berger T; Reindl M
    Curr Med Chem; 2009; 16(36):4858-68. PubMed ID: 19929782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies for the treatment of multiple sclerosis].
    Sánchez-Seco VG; Casanova Peño I; Arroyo González R
    Med Clin (Barc); 2014 Dec; 143 Suppl 3():30-4. PubMed ID: 25732947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody treatments for multiple sclerosis.
    Rose JW; Foley J; Carlson N
    Curr Neurol Neurosci Rep; 2008 Sep; 8(5):419-26. PubMed ID: 18713579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating multiple sclerosis with monoclonal antibodies.
    Buttmann M; Rieckmann P
    Expert Rev Neurother; 2008 Mar; 8(3):433-55. PubMed ID: 18345973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological treatment of multiple sclerosis].
    Sørensen PS; Sellebjerg F
    Ugeskr Laeger; 2008 Jun; 170(24):2156-9. PubMed ID: 18565303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
    Deiß A; Brecht I; Haarmann A; Buttmann M
    Expert Rev Neurother; 2013 Mar; 13(3):313-35. PubMed ID: 23448220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies targeting B-cells in multiple sclerosis.
    Milo R
    Autoimmun Rev; 2016 Jul; 15(7):714-8. PubMed ID: 26970489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of antibody therapy in demyelinating diseases.
    Akaishi T; Nakashima I
    Int Immunol; 2017 Jul; 29(7):327-335. PubMed ID: 28910968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies in treatment of multiple sclerosis.
    Rommer PS; Dudesek A; Stüve O; Zettl UK
    Clin Exp Immunol; 2014 Mar; 175(3):373-84. PubMed ID: 24001305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management.
    Krajnc N; Bsteh G; Berger T; Mares J; Hartung HP
    Neurotherapeutics; 2022 Apr; 19(3):753-773. PubMed ID: 35378683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral-targeted immunotherapies in multiple sclerosis.
    Lulu S; Waubant E
    Neurotherapeutics; 2013 Jan; 10(1):34-43. PubMed ID: 23208729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
    Singer BA
    Semin Neurol; 2016 Apr; 36(2):140-7. PubMed ID: 27116720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials.
    Heliopoulos I; Patousi A
    Med Chem; 2018 Feb; 14(2):144-154. PubMed ID: 28875861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of new therapies for multiple sclerosis].
    Holmøy T; Celius EG
    Tidsskr Nor Laegeforen; 2011 May; 131(8):832-6. PubMed ID: 21556088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell depletion in the treatment of multiple sclerosis.
    Myhr KM; Torkildsen Ø; Lossius A; Bø L; Holmøy T
    Expert Opin Biol Ther; 2019 Mar; 19(3):261-271. PubMed ID: 30632834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular targeted therapy for neuroimmunological diseases].
    Nakashima I
    Brain Nerve; 2013 Nov; 65(11):1353-61. PubMed ID: 24200613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging monoclonal antibody therapies for multiple sclerosis.
    Cree B
    Neurologist; 2006 Jul; 12(4):171-8. PubMed ID: 16832236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.